• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-05-25

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) simplifies molecular weight estimation and transfer verification in SDS-PAGE and Western blot workflows, especially where compatibility with EDTA-sensitive protocols or fluorescent imaging is required. It is not intended for mass spectrometry or applications demanding unstained reference proteins.

• Triptolide Disrupts DNA Repair by Inhibiting DNA-PKcs Activi

  2026-05-25

  This study reveals that triptolide, a plant-derived compound, directly impairs genome integrity in human cells by inhibiting the enzymatic activity of DNA-PKcs, a central factor in non-homologous end joining DNA repair. The findings have significant implications for understanding triptolide’s cytotoxicity and for designing research on DNA damage responses and cancer therapeutics.

• Intestinal TM6SF2 Safeguards Against MASH via the Gut–Liver

  2026-05-24

  The reference study uncovers the protective role of intestinal TM6SF2 against metabolic dysfunction-associated steatohepatitis (MASH) by regulating gut barrier integrity and host–microbe interactions. These findings highlight new mechanistic links within the gut–liver axis and suggest therapeutic strategies targeting lipid signaling and inflammation pathways.

• Dissecting In Vitro Drug Response: Insights from Schwartz 20

  2026-05-23

  Schwartz's dissertation advances cancer drug evaluation by distinguishing between proliferative arrest and cell death in vitro, revealing that most agents—including alkylators—exert complex, time-dependent effects on both processes. This nuanced approach informs more accurate assay design and interpretation, with practical implications for optimizing cytotoxicity studies in cancer research.

• Etoposide (VP-16): Optimizing DNA Damage Assays in Cancer Re

  2026-05-22

  Etoposide (VP-16) from APExBIO empowers researchers to induce precise DNA double-strand breaks for apoptosis studies and cancer drug screening. This article provides actionable workflows, advanced troubleshooting, and data-driven optimization strategies for maximizing assay sensitivity and reproducibility.

• Mitochondrial Transfer and ER Remodeling in Orofacial Pain R

  2026-05-22

  Li et al. illuminate how satellite glial cells alleviate orofacial inflammatory pain through mitochondrial transfer to trigeminal neurons, mediated by ER membrane remodeling and ATL1-dependent mitophagy regulation. This research identifies novel therapeutic targets for peripheral pain and expands mechanistic understanding of neuro-glial mitochondrial dynamics.

• MK-2206 dihydrochloride: Precision Inhibition of Akt Signali

  2026-05-21

  MK-2206 dihydrochloride stands out as a selective, robust Akt pathway inhibitor, empowering researchers to dissect PI3K/Akt/mTOR signaling in cancer and beyond. Its reproducibility and compatibility with apoptosis and angiogenesis assays make it a cornerstone reagent for translational experiments requiring actionable pathway control.

• AMPK’s Dual Role in Autophagy and Energy Stress: New Insight

  2026-05-21

  This study overturns the long-standing view that AMPK activation directly induces autophagy during glucose starvation. Instead, it demonstrates that AMPK inhibits the autophagy-initiating kinase ULK1, restraining autophagy under energy stress while preserving the autophagic machinery for subsequent recovery. These findings fundamentally reshape our understanding of energy metabolism regulation and have broad implications for metabolic and disease research.

• OTUD3-SLC7A11 Axis Drives Sunitinib Resistance in ccRCC via

  2026-05-20

  The referenced study uncovers how OTUD3 stabilizes SLC7A11, thereby suppressing ferroptosis and promoting resistance to sunitinib in clear cell renal cell carcinoma (ccRCC). These findings clarify a key mechanism of therapeutic resistance and suggest that targeting OTUD3 could enhance the efficacy of ferroptosis-inducing treatments.

• CPI-613: Enhancing Tumor Cell Metabolism Studies and Apoptos

  2026-05-20

  CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) redefines cancer metabolism research by targeting mitochondrial enzymes crucial for tumor survival. This guide delivers actionable workflows, troubleshooting insights, and applied protocols for leveraging CPI-613 in apoptosis assays and metabolic studies, including acute myeloid leukemia and NSCLC models.

• Lipid Peroxidation (MDA) Assay Kit: Precision in Ferroptosis

  2026-05-19

  The Lipid Peroxidation (MDA) Assay Kit empowers researchers to quantify malondialdehyde with high sensitivity, offering dual colorimetric and fluorescence readouts. This versatile tool drives innovation in oxidative stress and drug resistance studies, supporting robust, reproducible workflows from basic to translational research.

• ECL Western Blotting Substrate: Protocol and Troubleshooting

  2026-05-19

  ECL Western Blotting Substrate (SKU K2187) provides a nonradioactive, luminol-based solution for sensitive horseradish peroxidase detection in Western blot assays. It streamlines protein detection by chemiluminescence, reducing background and allowing for re-probing, but is not suitable for fluorescent or radioisotopic workflows.

• Metoprolol Tartrate: Precision β1 Blockade in Cardiovascular

  2026-05-18

  Metoprolol Tartrate’s high selectivity for β1-adrenergic receptors empowers researchers to dissect cardiac signaling with unprecedented clarity, minimizing off-target effects that confound data. This guide details robust protocols, advanced troubleshooting, and workflow innovations—backed by recent comparative studies—to optimize cardiovascular and hematopoietic experiments.

• Mechanisms of Diuron-Induced Acute Kidney Injury via JAK2/ST

  2026-05-18

  This study integrates network toxicology, transcriptomics, and experimental validation to delineate how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute renal injury. The research identifies the JAK2/STAT1 pathway as a central mediator of Diuron nephrotoxicity, refining risk assessment and guiding future toxicological investigations.

• Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo

  2026-05-17

  Vacuolin-1 enables precise, reproducible inhibition of Ca2+-dependent lysosomal exocytosis, empowering advanced membrane repair and trafficking research. This article details experimental best practices, troubleshooting strategies, and real-world applications in disease modeling, distinguishing Vacuolin-1 as an essential tool for dissecting lysosomal function.

16469 records 1/1098 page Next 12345 下5页 Last page